These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1326962)
21. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1. Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930 [TBL] [Abstract][Full Text] [Related]
22. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
23. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. Philips M; Juul AG; Thorsen S Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688 [TBL] [Abstract][Full Text] [Related]
24. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. Hajjar KA J Clin Invest; 1993 Jun; 91(6):2873-9. PubMed ID: 8390492 [TBL] [Abstract][Full Text] [Related]
25. Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Felez J; Chanquia CJ; Levin EG; Miles LA; Plow EF Blood; 1991 Nov; 78(9):2318-27. PubMed ID: 1932747 [TBL] [Abstract][Full Text] [Related]
26. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. Cesarman GM; Guevara CA; Hajjar KA J Biol Chem; 1994 Aug; 269(33):21198-203. PubMed ID: 8063741 [TBL] [Abstract][Full Text] [Related]
27. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells. Rosenfeld L; Kuo A; Hirsh J; Klugherz B; Gardell SJ; Cines DB; Barnathan ES Blood; 1992 Sep; 80(6):1486-95. PubMed ID: 1520875 [TBL] [Abstract][Full Text] [Related]
28. Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Felez J; Chanquia CJ; Fabregas P; Plow EF; Miles LA Blood; 1993 Oct; 82(8):2433-41. PubMed ID: 8400293 [TBL] [Abstract][Full Text] [Related]
29. Study on the mechanism of the annexin II-mediated co-assembly of t-PA and plasminogen. Zhang X; Zhou H; Shen G; Liu Z; Hu Y; Wei W; Song S J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):21-3, 76. PubMed ID: 12658774 [TBL] [Abstract][Full Text] [Related]
30. Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis. Li XN; Koons JC; Benza RL; Parks JM; Varma VK; Bradley WA; Gianturco SH; Taylor KB; Grammer JR; Tabengwa EM; Booyse FM Biochemistry; 1996 May; 35(19):6080-8. PubMed ID: 8634250 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of tissue-type plasminogen activator (t-PA)-mediated plasminogen activation on the surface of endothelial cells by t-PA receptor. Fukao H; Ueshima S; Okada K; Matsuo O Blood Coagul Fibrinolysis; 2001 Jul; 12(5):413-4. PubMed ID: 11505087 [No Abstract] [Full Text] [Related]
32. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Beebe DP; Miles LA; Plow EF Blood; 1989 Nov; 74(6):2034-7. PubMed ID: 2478220 [TBL] [Abstract][Full Text] [Related]
33. Identification of an endothelial cell surface protein that binds plasminogen. Dudani AK; Hashemi S; Aye MT; Ganz PR Mol Cell Biochem; 1991 Dec; 108(2):133-9. PubMed ID: 1664040 [TBL] [Abstract][Full Text] [Related]
34. Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites. Barnathan ES; Kuo A; Van der Keyl H; McCrae KR; Larsen GR; Cines DB J Biol Chem; 1988 Jun; 263(16):7792-9. PubMed ID: 3131327 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression. Zhang WJ; Wojta J; Binder BR J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087 [TBL] [Abstract][Full Text] [Related]
36. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058 [TBL] [Abstract][Full Text] [Related]
37. Binding of recombinant variants of human tissue-type plasminogen activator (t-PA) to human umbilical vein endothelial cells. Stockinger H; Kubbies M; Rudolph R; Stern A; Kohnert U; Fischer S Thromb Res; 1992 Sep; 67(5):589-99. PubMed ID: 1333104 [TBL] [Abstract][Full Text] [Related]
38. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589 [TBL] [Abstract][Full Text] [Related]
39. [Effects of injury to endothelial cells on the binding of t-PA to cultured human umbilical vein endothelial cells]. Mi X; Song J Zhonghua Bing Li Xue Za Zhi; 1995 Jun; 24(3):156-8. PubMed ID: 7656381 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of a new butadiene derivative on the production of plasminogen activator inhibitor-1 in cultured bovine endothelial cells. Ohtani A; Takagi T; Hirano A; Murakami J; Sasaki Y J Biochem; 1996 Dec; 120(6):1203-8. PubMed ID: 9010771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]